Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
10.67
+0.15 (1.43%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bioventus Revenue
Bioventus had revenue of $138.96M in the quarter ending September 28, 2024, with 15.04% growth. This brings the company's revenue in the last twelve months to $555.06M, up 10.40% year-over-year. In the year 2023, Bioventus had annual revenue of $512.35M with 0.04% growth.
Revenue (ttm)
$555.06M
Revenue Growth
+10.40%
P/S Ratio
1.23
Revenue / Employee
$572,228
Employees
970
Market Cap
697.47M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Avanos Medical | 681.50M |
Ironwood Pharmaceuticals | 378.42M |
Evolus | 248.33M |
IRADIMED CORPORATION | 71.31M |
Relay Therapeutics | 10.01M |
Oculis Holding AG | 1.03M |
Keros Therapeutics | 651.00K |
BVS News
- 6 weeks ago - Bioventus Inc. (BVS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Bioventus Reports Third Quarter Financial Results - GlobeNewsWire
- 7 weeks ago - Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 - GlobeNewsWire
- 4 months ago - Executives Buying W. P. Carey And 2 Other Stocks - Benzinga
- 4 months ago - Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024 - Seeking Alpha
- 4 months ago - Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference - GlobeNewsWire
- 4 months ago - Bioventus Reports Second Quarter Financial Results - GlobeNewsWire